Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential

Fig. 3

Splicing components as therapeutic targets. A number of techniques have been developed to chemically regulate splicing, in order to avoid the harmful effect of its dysregulation. Those techniques include chemical inhibitors of the core (top panel), regulators of splicing factors, like kinases inhibitors (middle panel), and oligonucleotides that bind to regulator sequences (bottom panel)

Back to article page